Studies

ID Name Stage Status
CRAD001CDE21T   Everolimus for patients with relapsed/refractory germ cell tumors (RADIT) relapse good prognosis
relapse poor prognosis
late relapse
 active
AH 10/04   1x BEP vs. 2x BEP for patients with high risk stage I nonseminoma stage I
 active
    Registry for the treatment of germ cell cancer brain metastasis various active
    Registry for the salvage treatment of relapsed/refractory germ cell cancer relapse good prognosis
relapse poor prognosis
late relapse
 active
CUOG-TE 05   Sunitinin for relapsed/refractory germ cell cancer (SUITE) relapse poor prognosis
 closed
    Gemcitabine/oxaliplatin/paclitaxel for relapsed/refractory germ cell tumors (GOP) relapse poor prognosis
 closed
AH 09/03   BEP ± darbepoetin metastatic good prognosis
metastatic intermediate prognosis
 closed
    High-dose chemotherapy PEI ± Darbepoetin metastatic poor prognosis
 closed
    Adjuvant etoposide after high-dose chemotherapy various closed
EORTC 30974   HD-PEI vs. PEB in poor prognosis patients metastatic poor prognosis
 closed
    Evaluation of late toxicities after high-dose chemotherapy various closed
EORTC 30983   Taxol-BEP vs. BEP for patients with intermediate prognosis metastatic intermediate prognosis
 closed
AH 08/02   Correlation between height and risk for testicular cancer various closed
AH 07/00   Diagnosis of testicular intraepithelial neoplasia TIN
 closed
AH 06/98   Role of positrone emission tomography (PET) various closed